Basic Information
Isotechnika Pharma Inc. is a biopharmaceutical company focused on the discovery and development of immunomodulatory therapies, aiming to provide critical safety advantages over currently available therapies. Its lead drug, voclosporin, is a calcineurin inhibitor targeting an estimated $3 billion market for this class of immunosuppressants.
Isotechnika Pharma Inc.
Edmonton,Alberta,Canada
15~50 people
January 01, 1993
--